InvestorsHub Logo
icon url

tscott4

09/09/20 5:17 AM

#16825 RE: agmcsf #16824

I believe US patient load is almost done or is done. Brazil Is the one they are waiting on. They got approved for Brazil in August doesn’t mean they started in August on that date. And during presentation they said we are past 50% enrollement not at 50% enrollement. Disease process for results is about 14 days. They are not going to rush the study either. They will take their time, possibly pick certain patients with PMH age sex race so study is balanced. They want this to get EUA clearance on spot of review but not only that the ability to expand studies into other studies like asthma COPD autoimmune. This drug is very significant bc GM CSF is becoming more and more supported by research in A lot of disease process. Also the IL6 failures will open door for GM CSF significantly.

Study needs to be perfect!